Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm). [electronic resource]
Producer: 20170112Description: 22398 p. digitalISSN:- 2045-2322
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine -- adverse effects
- Animals
- Calcium Signaling -- genetics
- Coordination Complexes
- Disease Models, Animal
- Dopamine -- biosynthesis
- Dopaminergic Neurons -- metabolism
- MPTP Poisoning -- genetics
- Mice
- Mice, Inbred C57BL
- Neuroprotective Agents -- therapeutic use
- Organometallic Compounds -- therapeutic use
- Parkinson Disease -- genetics
- Parkinson Disease, Secondary -- chemically induced
- Substantia Nigra -- drug effects
- Synaptic Transmission -- genetics
- Thiosemicarbazones -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.